Velcade and Skin sensitisation - a phase IV clinical study of FDA data

Summary:

Skin sensitisation is reported as a side effect among people who take Velcade (bortezomib), especially for people who are male, 60+ old, also take Revlimid, and have Neuralgia.

The phase IV clinical study analyzes which people have Skin sensitisation when taking Velcade. It is created by eHealthMe based on reports of 66,250 people who have side effects when taking Velcade from the FDA, and is updated regularly.

What is Velcade?

Velcade has active ingredients of bortezomib. It is often used in multiple myeloma. eHealthMe is studying from 66,422 Velcade users. Check the latest studies of Velcade.

What is Skin sensitisation?

Skin sensitisation (sensitive skin) is found to be associated with 177 drugs and 318 conditions by eHealthMe. Check the latest studies of Skin sensitisation.

On Jul, 11, 2026

66,250 people reported to have side effects when taking Velcade.
Among them, 12 people (0.02%) have Skin sensitisation.

Among these 12 people:

What is the gender of people who have Skin sensitisation when taking Velcade? *

female: 50 %
male: 50 %

What is the age of people who have Skin sensitisation when taking Velcade? *

What are other drugs people take besides Velcade? *

What are other side effects people have besides Skin sensitisation? *

Neuropathy Peripheral (surface nerve damage): 5 people, 41.67%
Fatigue (feeling of tiredness): 5 people, 41.67%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 4 people, 33.33%
Nasopharyngitis (inflammation of the nasopharynx): 3 people, 25.00%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 16.67%
Feeling Abnormal: 2 people, 16.67%
Back Pain: 2 people, 16.67%
Compression Fracture (fracture due to pressure caused by injury): 2 people, 16.67%
Peripheral Swelling: 2 people, 16.67%
Constipation: 2 people, 16.67%

What are the existing conditions these people have? *

Neuralgia (pain in one or more nerves): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Velcade and have Skin sensitisation?

- Check whether Skin sensitisation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Velcade:

Velcade (66,422 reports)

Browse all side effects of Velcade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin sensitisation:

Skin sensitisation (177 drugs)

Browse all the conditions that are associated with Skin sensitisation:

Skin sensitisation (318 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bortezomib (the active ingredients of Velcade) and Velcade (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.